The initial biopharmaceutical companies committed to launching BioCelerate include Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Novo Nordisk and Shionogi & Co., Ltd.
X
By using our website, you consent to us sharing your information with third party marketing and analytics partners. We use cookies for social media, analytics and advertising purposes. For more information, see our Privacy Policy. Our Terms apply.